Conversely, another study has suggested that activation of SIRT1 inhibited the proliferation of pancreatic cancer cells that expressed the oncogene pancreatic adenocarcinoma up-regulated factor (PAUF) and that SIRT1 activation could be a novel therapeutic strategy [25]. Here, SIRT1 is linked to pancreatic adenocarcinoma.